History
HEM Pharma has been constantly making efforts to add more abundance and happiness to life of human beings.
In order to change the world with new challenges to realize the ideal life that everyone dreams of,
HEM Pharma will continue to open a new history in the microbiome field through technological innovation that goes beyond limits.
2022
- June
- Selected as ‘Preliminary Unicorn’ at K- Unicorn Project by
Ministry of Science and ICT
- May
- Launching Amway my LAB by Nutrilite
- February
- Establishing U.S. intestinal microbiome data through
clinical research agreement with Endominance
2021
- December
- Receiving the grand prize at '2021 Korea's Excellent Patent'
- May
- Changing company name to HEM Pharma Inc
- February
- GMP production facility completed
- January
- Launching Amway Balace Within Immunity
2020
- September
-
Starting LARS efficacy evaluation clinical start,
ISO 9001 quality management system certification
- April
-
Changing company name to HEM Inc,
Launching post-synergy service
- March
- Launching intestinal microbe-metabolome research service
- January
- Contracting an exclusive contract for the sale of Access
Business Group My Lab Service
2019
- September
- Concluding a business contract with COSMAX NBT for research
exchange and cooperation in product development and sales
2018
- December
- Certification of Korea Venture Company
- June
- Recognition as a corporation affiliation research institute
- April
- Establishing HEM Suwon Gwanggyo branch of Advanced Institute of
Convergence Technology
2017
- August
- Concluding MOU with Lactomason Inc. and proceeding technology transfer
- From May
to present
- Israel’s Better Air won a contract to transfer useful microbial technology
for a total of $600,000 worth of environmental purification
- January
- Starting the business of Holzapfel Effective Microbes
(2016.12.30 establishment registration)